Cargando…
Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation
BACKGROUND: Non-traditional CD4+CD25–CD69+ T cells were found to be involved in disease progression in tumor-bearing mouse models and cancer patients recently. We attempted to define whether this subset of T cells were related to leukemia relapse after allogeneic hematopoietic cell transplantation (...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089938/ https://www.ncbi.nlm.nih.gov/pubmed/24984576 http://dx.doi.org/10.1186/1479-5876-12-187 |
_version_ | 1782325201298522112 |
---|---|
author | Zhao, Xiao-su Wang, Xu-hua Zhao, Xiang-yu Chang, Ying-jun Xu, Lan-ping Zhang, Xiao-hui Huang, Xiao-jun |
author_facet | Zhao, Xiao-su Wang, Xu-hua Zhao, Xiang-yu Chang, Ying-jun Xu, Lan-ping Zhang, Xiao-hui Huang, Xiao-jun |
author_sort | Zhao, Xiao-su |
collection | PubMed |
description | BACKGROUND: Non-traditional CD4+CD25–CD69+ T cells were found to be involved in disease progression in tumor-bearing mouse models and cancer patients recently. We attempted to define whether this subset of T cells were related to leukemia relapse after allogeneic hematopoietic cell transplantation (allo-HSCT). METHODS: The frequency of CD4+CD25–CD69+ T cells among the CD4+ T cell population from the bone marrow of relapsed patients, patients with positive minimal residual disease (MRD+) and healthy donors was examined by flow cytometry. The CD4+CD25-CD69+ T cells were also stained with the intracellular markers to determine the cytokine (TGF-β, IL-2 and IL-10) secretion. RESULTS: The results showed that the frequency of CD4+CD25–CD69 + T cells was markedly increased in patients in the relapsed group and the MRD + group compared to the healthy donor group. The percentage of this subset of T cells was significantly decreased after effective intervention treatment. We also analyzed the reconstitution of CD4+CD25–CD69+ T cells at various time points after allo-HSCT, and the results showed that this subset of T cells reconstituted rapidly and reached a relatively higher level at +60 d in patients compared to controls. The incidence of either MRD+ or relapse in patients with a high frequency of CD4+CD25-CD69+ T cells (>7%) was significantly higher than that of patients with a low frequency of CD4+CD25-CD69+ T cells at +60 d, +90 d and +270 d after transplant. However, our preliminary data indicated that CD4+CD25-CD69+ T cells may not exert immunoregulatory function via cytokine secretion. CONCLUSIONS: This study provides the first clinical evidence of a correlation between non-traditional CD4+CD25-CD69+ Tregs and leukemia relapse after allo-HSCT and suggests that exploration of new methods of adoptive immunotherapy may be beneficial. Further research related to regulatory mechanism behind this phenomenon would be necessary. |
format | Online Article Text |
id | pubmed-4089938 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40899382014-07-10 Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation Zhao, Xiao-su Wang, Xu-hua Zhao, Xiang-yu Chang, Ying-jun Xu, Lan-ping Zhang, Xiao-hui Huang, Xiao-jun J Transl Med Research BACKGROUND: Non-traditional CD4+CD25–CD69+ T cells were found to be involved in disease progression in tumor-bearing mouse models and cancer patients recently. We attempted to define whether this subset of T cells were related to leukemia relapse after allogeneic hematopoietic cell transplantation (allo-HSCT). METHODS: The frequency of CD4+CD25–CD69+ T cells among the CD4+ T cell population from the bone marrow of relapsed patients, patients with positive minimal residual disease (MRD+) and healthy donors was examined by flow cytometry. The CD4+CD25-CD69+ T cells were also stained with the intracellular markers to determine the cytokine (TGF-β, IL-2 and IL-10) secretion. RESULTS: The results showed that the frequency of CD4+CD25–CD69 + T cells was markedly increased in patients in the relapsed group and the MRD + group compared to the healthy donor group. The percentage of this subset of T cells was significantly decreased after effective intervention treatment. We also analyzed the reconstitution of CD4+CD25–CD69+ T cells at various time points after allo-HSCT, and the results showed that this subset of T cells reconstituted rapidly and reached a relatively higher level at +60 d in patients compared to controls. The incidence of either MRD+ or relapse in patients with a high frequency of CD4+CD25-CD69+ T cells (>7%) was significantly higher than that of patients with a low frequency of CD4+CD25-CD69+ T cells at +60 d, +90 d and +270 d after transplant. However, our preliminary data indicated that CD4+CD25-CD69+ T cells may not exert immunoregulatory function via cytokine secretion. CONCLUSIONS: This study provides the first clinical evidence of a correlation between non-traditional CD4+CD25-CD69+ Tregs and leukemia relapse after allo-HSCT and suggests that exploration of new methods of adoptive immunotherapy may be beneficial. Further research related to regulatory mechanism behind this phenomenon would be necessary. BioMed Central 2014-07-01 /pmc/articles/PMC4089938/ /pubmed/24984576 http://dx.doi.org/10.1186/1479-5876-12-187 Text en Copyright © 2014 Zhao et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zhao, Xiao-su Wang, Xu-hua Zhao, Xiang-yu Chang, Ying-jun Xu, Lan-ping Zhang, Xiao-hui Huang, Xiao-jun Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation |
title | Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation |
title_full | Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation |
title_fullStr | Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation |
title_full_unstemmed | Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation |
title_short | Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation |
title_sort | non-traditional cd4+cd25−cd69+ regulatory t cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089938/ https://www.ncbi.nlm.nih.gov/pubmed/24984576 http://dx.doi.org/10.1186/1479-5876-12-187 |
work_keys_str_mv | AT zhaoxiaosu nontraditionalcd4cd25cd69regulatorytcellsarecorrelatedtoleukemiarelapseafterallogeneichematopoieticstemcelltransplantation AT wangxuhua nontraditionalcd4cd25cd69regulatorytcellsarecorrelatedtoleukemiarelapseafterallogeneichematopoieticstemcelltransplantation AT zhaoxiangyu nontraditionalcd4cd25cd69regulatorytcellsarecorrelatedtoleukemiarelapseafterallogeneichematopoieticstemcelltransplantation AT changyingjun nontraditionalcd4cd25cd69regulatorytcellsarecorrelatedtoleukemiarelapseafterallogeneichematopoieticstemcelltransplantation AT xulanping nontraditionalcd4cd25cd69regulatorytcellsarecorrelatedtoleukemiarelapseafterallogeneichematopoieticstemcelltransplantation AT zhangxiaohui nontraditionalcd4cd25cd69regulatorytcellsarecorrelatedtoleukemiarelapseafterallogeneichematopoieticstemcelltransplantation AT huangxiaojun nontraditionalcd4cd25cd69regulatorytcellsarecorrelatedtoleukemiarelapseafterallogeneichematopoieticstemcelltransplantation |